BioStem Technologies to acquire wound care products and technologies from ProgenaCare Global
BioStem Technologies to acquire wound care products and technologies from ProgenaCare Global
157.49MUSD
Type
Common Stock
Exchange
OTCQB
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US0906842002
CUSIP
090684200
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
1.40
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.57
Wall Street Target Price
32.50
EPS Estimate Current Year
1.41
EPS Estimate Next Year
2.29
EPS Estimate Current Quarter
0.47
EPS Estimate Next Quarter
0.65
Most Recent Quarter
-
Revenue TTM
210,494,096
Gross Profit TTM
199,654,608
EBITDA
22,674,176
Profit Margin
7.53%
Return On Assets TTM
25.51%
Return On Equity TTM
164.25%
Revenue Per Share TTM
13.069
Qtly Revenue Growth YOY
2258.90%
Diluted Eps TTM
-0.57
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
4
Price Sales TTM
0.7831
Price Book MRQ
0
Enterprise Value Revenue
9
Enterprise Value EBITDA
-24
278.95
9.87%80.47
0.68%155.00
0.00%252.84
-3.71%97.06
-1.75%651.62
-1.62%190.32
-1.26%503.95
-1.20%95.34
-0.88%612.81
-0.20%